News - Cortado Ventures

Recent Cortado news, media & events

Blog Posts | Newsletters | Podcasts

Recent news & events

GeoMark Research and Senslytics Forge Strategic Partnership to Pioneer Breakthroughs in Artificial Intelligence Solutions

Dec 4, 2023 | Partner Articles

For media inquiries, please contact: Graham Spence, Vice President Sales gspence@geomarkresearch.com GeoMark Research and Senslytics Forge Strategic Partnership to Pioneer Breakthroughs in Artificial Intelligence Solutions Houston, Dec. 4, 2023 — GeoMark Research,...

Payfactory and the Future of Embedded Payments: Q&A with Payfactory founder Ruston Miles

Nov 15, 2023 | Blog, Media, Portfolio Companies

Read the full story here Authored by Susan Moring, Cortado Ventures General Partner One of our favorite types of startups to invest in at Cortado are those who are building underlying technologies that enable businesses and industries to operate more...

Nathaniel Harding featured on podcasts

Nov 14, 2023 | Media

"Your optimism and the narrative you tell yourself that this needs to happen and I'm the one to do it is what keeps you going.” Our managing partner, Nathaniel Harding has been featured on four podcasts recently. Check out these episodes: The Daily Grind: Check out...

nSight Surgical Honored with Surgical Transformation award

Nov 2, 2023 | Media

Great news! Congratulations to one of our portcos, nSight Surgical for receving Best in Class for Surgical Transformation award at the 2023 HLTH awards. To watch the ceremony (1:03:47): https://www.youtube.com/watch?v=bSIdo0YtA6M&t=3674s

TIME Magazine Honors NuView & Pipedream: Best Inventions

Nov 2, 2023 | Media

TIME Magazine has named NUVIEW & Pipedream Labs as two of the best inventions of the year! We're proud to back this groundbreaking technology. #TIMEBestInventions. Congratulations to Nuview & Pipedream Labs.

Why We Invested: Moat Biotechnology

Nov 2, 2023 | Blog

At Cortado Ventures, we back entrepreneurs that are inventing the future, and we are thrilled about our investment in Moat Biotechnology. Moat’s technology is based on a next-generation adenovirus platform from the Mayo Clinic. Our General Partner Mike Moradi...